(ARA) — Nearly 19 million Americans currently live with Gastroesophageal Reflux Disease (GERD), commonly known as acid reflux disease, and suffer from painful and uncomfortable symptoms such as frequent and persistent heartburn.
The Food and Drug Administration (FDA) recently approved KAPIDEX (TM) (dexlansoprazole) delayed release capsules for the once-daily, oral treatment of heartburn associated with symptomatic [...]

(ARA) — Nearly 19 million Americans currently live with Gastroesophageal Reflux Disease (GERD), commonly known as acid reflux disease, and suffer from painful and uncomfortable symptoms such as frequent and persistent heartburn.
The Food and Drug Administration (FDA) recently approved KAPIDEX (TM) (dexlansoprazole) delayed release capsules for the once-daily, oral treatment of heartburn associated with symptomatic [...]